| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |